IRIS
ORANGER, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.810
AS - Asia 2.193
EU - Europa 1.777
SA - Sud America 583
AF - Africa 173
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.543
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.732
SG - Singapore 984
CN - Cina 584
BR - Brasile 498
IT - Italia 411
SE - Svezia 344
HK - Hong Kong 279
RU - Federazione Russa 253
DE - Germania 226
UA - Ucraina 163
CI - Costa d'Avorio 136
VN - Vietnam 133
FI - Finlandia 121
GB - Regno Unito 96
IN - India 49
CA - Canada 42
FR - Francia 38
AR - Argentina 34
ID - Indonesia 33
MX - Messico 27
IE - Irlanda 22
NL - Olanda 22
PL - Polonia 21
BD - Bangladesh 18
JP - Giappone 17
ZA - Sudafrica 16
TR - Turchia 15
ES - Italia 12
IQ - Iraq 11
VE - Venezuela 11
AT - Austria 10
IR - Iran 10
LT - Lituania 10
CO - Colombia 9
PY - Paraguay 9
BE - Belgio 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EC - Ecuador 7
PK - Pakistan 7
CL - Cile 6
CZ - Repubblica Ceca 6
MA - Marocco 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
KR - Corea 5
PE - Perù 5
AU - Australia 4
BY - Bielorussia 4
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
TN - Tunisia 3
AM - Armenia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MN - Mongolia 2
NP - Nepal 2
RO - Romania 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.543
Salva come PNG Salva come JPEG
Città #
Singapore 520
Ashburn 457
Fairfield 414
Chandler 390
Jacksonville 371
Woodbridge 348
Hong Kong 279
Nyköping 247
Houston 244
Bari 214
Cambridge 184
Ann Arbor 173
Beijing 168
Seattle 162
Abidjan 136
Dallas 136
Wilmington 136
Roxbury 95
New York 94
Lawrence 92
Nanjing 87
Los Angeles 86
Munich 69
Des Moines 65
Boardman 56
Brooklyn 48
Ho Chi Minh City 48
São Paulo 48
Princeton 42
Inglewood 40
Buffalo 37
Dearborn 37
San Diego 33
Shenyang 32
Hanoi 30
Santa Clara 29
Jakarta 26
London 26
Nanchang 26
Pune 23
Dublin 22
Warsaw 21
Changsha 19
Guangzhou 18
Turku 18
Chicago 17
Hebei 17
Helsinki 17
Jiaxing 17
Moscow 17
Johannesburg 15
Montreal 15
Noicattaro 15
Tianjin 14
Tokyo 14
Toronto 14
Trani 14
Atlanta 13
Phoenix 13
Rome 13
Mexico City 12
Paris 12
Redwood City 12
San Francisco 12
Belo Horizonte 11
Denver 11
Falkenstein 11
Rio de Janeiro 11
Frankfurt am Main 10
Hefei 10
Manchester 10
Boydton 9
Orta Nova 9
Salvador 9
Stockholm 9
Wuhan 9
Brussels 8
Chennai 8
Council Bluffs 8
Salt Lake City 8
Ardabil 7
Boston 7
Brasília 7
Curitiba 7
Falls Church 7
Kunming 7
Melito Di Napoli 7
Milan 7
Norwalk 7
Orem 7
Poplar 7
Shanghai 7
The Dalles 7
Ankara 6
Brno 6
Campinas 6
Charlotte 6
Leawood 6
Nuremberg 6
San Mateo 6
Totale 6.403
Salva come PNG Salva come JPEG
Nome #
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 192
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α 184
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems 179
Sclerostin stimulates angiogenesis in human endothelial cells 151
TRAIL effect on osteoclast formation in physiological and pathological conditions 148
Aortic valvular interstitial cells apoptosis and calcification is mediated by TNF-related apoptosis-inducing ligand 141
Alteration of the osteogenic properties of bone marrow stromal cells from multiple myeloma bone disease patients 132
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 131
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 127
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 127
Cellular mechanisms of multiple myeloma bone disease 125
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 125
Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 123
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 123
Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL 121
Osteogenic differentiation of dental follicle stem cells. 118
TRAIL is involved in human osteoclast apoptosis 113
Another link between bone and immune system: LIGHT 110
THE ROLE OF LIGHT ON BONE REMODELING 109
Altered osteogenic properties of bone marrow stromal cells from multiple myeloma patients 109
Alteration of bone remodeling in multiple myeloma bone disease: role of sclerostin 108
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 106
In vitro osteoclastogenesis and T-cell RANKL expression in multiple myeloma-bone disease at diagnosis and in the setting of frontline treatment 105
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis 105
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 105
Osteoblast Apoptosis in Periodontal Disease: Role of TNF-related apoptosis-inducing ligand 105
The effect of Irisin on bone cells in vivo and in vitro 103
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 102
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 100
Alterazione del rimodellamento osseo in soggetti in età pediatrica affetti da deficit di 21-idrossilasi (21-OHD): ruolo di DKK1 99
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 99
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 99
Elevati livelli sierici di Dkk1, antagonista del segnale di WNT in bambini obesi. 98
Osteoblasts display different responsiveness to TRAIL- induced apoptosis during their differentiation process 98
Myeloma cells suppress osteoblasts through sclerostin secretion 98
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 98
The Role of LIGHT in Multiple Myeloma-Bone Disease 97
Alterazione delle capacità osteogeniche in cellule stromali ottenute da midollo osseo di pazienti affetti da mieloma multiplo 95
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 94
T cells support osteoclastogenesis in an in vitro model derived from psoritic arthritis 93
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 92
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 92
DCR3 involvement in multiple myeloma bone disease 91
Alterazione del potenziale osteogenico in osteoblasti ottenuti da soggetti affetti da malattia parodontale: ruolo dei recettori apoptotici per TRAIL 91
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 91
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 90
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 89
Failure of an in vitro model of osteoclastogenesis in human plasma cell leukaemia (PCL) 86
The role of the Wnt-signaling antagonist Sclerostin in the development of osteolytic lesions in multiple myeloma 84
Myeloma cells induce osteoblast suppression through sclerostin secretion 84
Circulating levels of cathepsin-k in multiple myeloma patients 84
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 84
Mechanism of Bone Disease in Prader-Willi Syndrome 83
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis. 81
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 81
DcR3 involvement in multiple myeloma bone disease 81
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 80
Bone Cells 80
Dental pulp stem cells: osteogenic differentiation and genes expression 79
Irisin and Secondary Osteoporosis in Humans 78
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 75
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 75
Soluble decoy receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 75
null 74
High levels of LIGHT/TNFSF14 in patients with Prader–Willi syndrome 73
LIGHT: another link between bone and immune system 73
Osteoclast apoptosis: Role of TRAIL and its receptors 72
Spontaneous osteoclastogenesis TNF-a and RANKL mediated in patients with Turner syndrome. 71
null 71
Sclerostin, produced by myeloma plasma cell, suppresses osteoblast activity 70
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 69
The role of light (TNFSF14) on bone remodeling 69
LIGHT: a new potential molecule involved in bone loss 68
No spontaneous osteoclast formation in an in vitro model derived from primary plasma cell leukemia 68
Osteogenic properties of human dental pulp stem cells 67
Inflammatory Cells in Diffuse Large B Cell Lymphoma 66
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease 66
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 65
Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome 65
Osteoclastogensi spontanea TNF-alpha e RANKL mediata in pazienti con Sindrome di Turner 64
Impairment of osteoblast diffeentiation and activity through sclerostin in multiple myeloma bone disease ??? 64
Detection of the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 64
Osteoblast apoptosis in periodontal disease: role of TRAIL 64
null 63
Survival and formation of osteoclasts from multiple myeloma bone disease patients: role of decoy receptor 3 (DCR3) 63
Osteoclast formation in Multiple Myeloma bone disease patients: role of DcR3 62
The role of the Wnt-signaling antagonist sclerostin in the development of osteolytic lesions in multiple myeloma 62
High serum levels of the WNT-signaling antagonist Dkk1 in obese children 61
Evaluation of serum levels of cathepsin k in multiple myeloma patients 60
DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNFα up-regulation 60
TRAIL effect on osteoclast formation in multiple myeloma-bone disease 60
Formazione e sopravvivenza di osteoclasti in pazienti affetti da mieloma multiplo: ruolo di DcR3 59
Shedding LIGHT on bone cell differentiation and Multiple Myeloma-bone disease 59
Inhibition of osteoclast apoptosis in multiple myeloma bone diseases: role of DCR3 58
High serum levels of the WNT-signaling antagonist Dkk1 in children with 21-hydroxylase deficiency (21-OHD) 57
Le cellule T supportano la formazione di osteoclasti in vitro in campioni di sangue periferico ottenuti da pazienti affetti da artrite psoriasica 57
Ridotta attività degli osteoblasti nel mieloma multiplo: ruolo della sclerostina 57
Formazione di osteoclasti in un modello in vitro derivato da pazienti affetti da mieloma multiplo: interazione OPG/TRAIL 56
IN VITRO EVALUATION OF OSTEOGENIC PROPERTIES OF HUMAN DENTAL PULP STEM CELLS 55
DcR3 involvement in multiple myeloma bone disease 54
Totale 8.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021513 0 0 0 0 0 48 87 54 111 114 65 34
2021/2022802 27 108 5 32 26 50 28 35 128 40 134 189
2022/20231.144 166 122 64 85 140 134 22 131 228 5 18 29
2023/2024425 45 84 12 27 35 114 8 4 1 27 25 43
2024/20252.061 127 27 141 70 47 201 285 165 70 134 267 527
2025/20262.360 634 213 430 510 504 69 0 0 0 0 0 0
Totale 9.771